The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1267 articles
Many users of GLP-1 medications are reporting an unexpected and costly side effect: a profound fascination with perfume. This article delves into the phenomenon, exploring user experiences and expert theories.
The effectiveness of GLP-1 medications like Ozempic, Wegovy, and Mounjaro for weight loss has led to widespread adoption. However, a concerning trend is emerging: individuals with a history of or current eating disorders are increasingly turning to these drugs, raising alarm bells among healthcare professionals dedicated to eating disorder recovery.
Popular GLP-1 medications such as semaglutide and tirzepatide are revolutionizing weight loss and diabetes management. A groundbreaking study using AI to analyze over 400,000 Reddit posts has shed light on potential side effects that may not be fully captured in traditional clinical trials, offering valuable insights for patients and healthcare providers.
While GLP-1 medications have revolutionized weight loss and diabetes management, their powerful effects can lead to surprising side effects beyond the commonly known nausea and digestive issues. This article delves into these less-discussed risks, from dental health concerns to serious gastrointestinal complications, and offers practical advice for patients and healthcare providers.
The GLP-1 analogue market is experiencing unprecedented growth, transforming from diabetes treatments to comprehensive cardiometabolic solutions. Discover the key drivers, leading medications, and future innovations shaping this dynamic field.
Rapid weight loss from GLP-1 medications can lead to temporary hair thinning. This article explores the causes of this common side effect and provides actionable advice for managing and encouraging hair regrowth, drawing on personal experiences and expert insights.
The rise of GLP-1 medications is sparking conversations about beauty standards, with some experts predicting a shift towards a 'GLP-1 face' aesthetic. This article delves into the science, societal impact, and artistic implications of this evolving trend.
A recent study has raised questions about a rare but serious eye condition linked to Wegovy. Learn more about ischemic optic neuropathy (ION) and what this research means for patients using GLP-1 medications.
New data suggests Eli Lilly's retatrutide could deliver up to 28% weight loss, potentially rivaling bariatric surgery. Learn about efficacy and safety.
